Associated Papers
Deep Sequencing Reveals Novel Mutations in Androgen Receptor-Related Genes in Prostate Cancer.
Pedroza-Torres A et al.
International Journal of Molecular Sciences, 2025
Feasibility of long-read sequencing to identify molecular alterations in an Indonesian cohort of locally advanced to advanced nasopharyngeal cancer.
Handoko et al.
Scientific Reports, 2025
Molecular insights into TP53 mutation (p. Arg267Trp) and its connection to Choroid Plexus Carcinomas and Li-Fraumeni Syndrome.
Abduljaleel Z
Genes & Genomics, 2024
Previously reported CCDC26 risk variant and novel germline variants in GALNT13, AR, and MYO10 associated with familial glioma in Finland.
Nurminen R et al.
Scientific Reports, 2024
TP53 germline pathogenic variants in modern humans were likely originated during recent human history.
Kou SH et al.
Nar Cancer, 2023
The Olfactory Receptor Gene Product, OR5H2, Modulates Endometrial Cancer Cells Proliferation via Interaction with the IGF1 Signaling Pathway.
Shibel R et al.
Cells, 2021
Identification and functional characterization of new missense SNPs in the coding region of the TP53 gene.
Doffe F et al.
Cell Death and Differentiation, 2021
Prevalence of germline TP53 variants among early-onset breast cancer patients from Polish population.
Rogoża-Janiszewska E et al.
Breast Cancer (tokyo, Japan), 2021
A deep analysis using panel-based next-generation sequencing in an Ecuadorian pediatric patient with anaplastic astrocytoma: a case report.
García-Cárdenas JM et al.
Journal of Medical Case Reports, 2020
Pattern of nucleotide variants of TP53 and their correlation with the expression of p53 and its downstream proteins in a Sri Lankan cohort of breast and colorectal cancer patients.
Manoharan V et al.
Bmc Cancer, 2020
Identification of ZYG11A as a candidate IGF1-dependent proto-oncogene in endometrial cancer.
Achlaug L et al.
Oncotarget, 2019
Nucleotide variants and protein expression of TP53 in a Sri Lankan cohort of patients with head and neck cancer.
Manoharan V et al.
Molecular Medicine Reports, 2019
Incidental detection of germline variants of potential clinical significance by massively parallel sequencing in haematological malignancies.
Yannakou CK et al.
Journal of Clinical Pathology, 2018
TP53 Mutation Status of Tubo-ovarian and Peritoneal High-grade Serous Carcinoma with a Wild-type p53 Immunostaining Pattern.
Na K et al.
Anticancer Research, 2017
Germline TP53 mutational spectrum in French Canadians with breast cancer.
Arcand SL et al.
Bmc Medical Genetics, 2015
Detection of p53 common intron polymorphisms in patients with gastritis lesions from Iran.
Najjar Sadeghi R et al.
Asian Pacific Journal of Cancer Prevention : Apjcp, 2013
Investigation of genetic polymorphisms related to the outcome of radiotherapy for prostate cancer patients.
Cintra HS et al.
Disease Markers, 2013
Association of intron and exon polymorphisms of p53 gene in Iranian patients with gastritis.
Najjar Sadeghi R et al.
Gastroenterology and Hepatology From Bed to Bench, 2013
Prevalence of TP53 germ line mutations in young Pakistani breast cancer patients.
Rashid MU et al.
Familial Cancer, 2012
IDH1 and IDH2 mutations, immunohistochemistry and associations in a series of brain tumors.
Mellai M et al.
Journal of Neuro-oncology, 2011
Beyond BRCA1 and BRCA2 wild-type breast and/or ovarian cancer families: germline mutations in TP53 and PTEN.
Blanco A et al.
Clinical Genetics, 2010
TP53 mutations in human cancers: origins, consequences, and clinical use.
Olivier M et al.
Cold Spring Harbor Perspectives in Biology, 2010
Comprehensive analysis of genomic alterations in gliosarcoma and its two tissue components.
Actor B et al.
Genes, Chromosomes & Cancer, 2002